Cognitive behavioral therapy in combination with pharmacotherapy for adults with ADHD
BACKGROUND: Treatment options for attention deficit hyperactivity disorder (ADHD) in adults consist of psycho-education, cognitive behavioral therapy (CBT), pharmacotherapy or a combination thereof.
AIM: To investigate the effect of CBT combined with pharmacotherapy on the quality of life in adults with ADHD compared to medication alone.
METHOD: In this multicenter prospective cohort study a total of 627 patients were included, 305 where included in the medication only group and 322 in de combination group (CBT and medication). The Adult ADHD Quality-of-Life scale (AAQoL) was conducted at baseline and at the end of treatment.
RESULTS: The quality of life as measured by the AAQoL increased significantly in both groups but was not significantly different between the two groups (p = 0.33).
CONCLUSION: To our knowledge, this is the first study to describe the effect of CBT as an addition to ADHD drug therapy on the quality of life in adults. Contrary to our expectations, there was no significant effect of CBT as an addition to drug therapy on the quality of life.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:63 |
|---|---|
| Enthalten in: |
Tijdschrift voor psychiatrie - 63(2021), 7 vom: 01., Seite 550-556 |
| Sprache: |
Niederländisch |
|---|
| Weiterer Titel: |
Cognitieve gedragstherapie bij medica-menteuze behandeling van ADHD bij volwassenen |
|---|
| Beteiligte Personen: |
Wettstein, R K R W [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 16.09.2021 Date Revised 16.09.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM330657771 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330657771 | ||
| 003 | DE-627 | ||
| 005 | 20231225211750.0 | ||
| 007 | tu | ||
| 008 | 231225s2021 xx ||||| 00| ||dut c | ||
| 028 | 5 | 2 | |a pubmed24n1102.xml |
| 035 | |a (DE-627)NLM330657771 | ||
| 035 | |a (NLM)34523707 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a dut | ||
| 100 | 1 | |a Wettstein, R K R W |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cognitive behavioral therapy in combination with pharmacotherapy for adults with ADHD |
| 246 | 3 | 3 | |a Cognitieve gedragstherapie bij medica-menteuze behandeling van ADHD bij volwassenen |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 16.09.2021 | ||
| 500 | |a Date Revised 16.09.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Treatment options for attention deficit hyperactivity disorder (ADHD) in adults consist of psycho-education, cognitive behavioral therapy (CBT), pharmacotherapy or a combination thereof | ||
| 520 | |a AIM: To investigate the effect of CBT combined with pharmacotherapy on the quality of life in adults with ADHD compared to medication alone | ||
| 520 | |a METHOD: In this multicenter prospective cohort study a total of 627 patients were included, 305 where included in the medication only group and 322 in de combination group (CBT and medication). The Adult ADHD Quality-of-Life scale (AAQoL) was conducted at baseline and at the end of treatment | ||
| 520 | |a RESULTS: The quality of life as measured by the AAQoL increased significantly in both groups but was not significantly different between the two groups (p = 0.33) | ||
| 520 | |a CONCLUSION: To our knowledge, this is the first study to describe the effect of CBT as an addition to ADHD drug therapy on the quality of life in adults. Contrary to our expectations, there was no significant effect of CBT as an addition to drug therapy on the quality of life | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 700 | 1 | |a Klabbers, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Romijn, E |e verfasserin |4 aut | |
| 700 | 1 | |a Nieuwveen, J |e verfasserin |4 aut | |
| 700 | 1 | |a Kroesen, J C |e verfasserin |4 aut | |
| 700 | 1 | |a Wettstein, K R M |e verfasserin |4 aut | |
| 700 | 1 | |a Dumont, G J H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Tijdschrift voor psychiatrie |d 2006 |g 63(2021), 7 vom: 01., Seite 550-556 |w (DE-627)NLM165211156 |x 0303-7339 |7 nnns |
| 773 | 1 | 8 | |g volume:63 |g year:2021 |g number:7 |g day:01 |g pages:550-556 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 63 |j 2021 |e 7 |b 01 |h 550-556 | ||